• SENSEX 80,999.40
    -28.62 (--0.04%)
  • BANKNIFTY 58,850.65
    -235.35 (--0.40%)
  • NSE
    1,941.95 1,953.95(%)
  • Finolex Cables
    1,309.90 1,498.35(%)
  • Tonbo Imaging
    1,529.90 1,644.50(%)
  • HDFC Bank
    783.20 668.90(%)
  • Divi's Lab.
    11,195.95 10,305.00(%)
  • Jio Platforms
    1,426.00 1,490.00(%)
  • Banco Products
    698.85 865.45(%)
  • Reliance Industries
    1,324.90 1,611.20(%)
  • R R Kabel
    2,147.75 2,980.00(%)
  • N S D L
    786.90 1,180.00(%)
  • TD Power Systems
    614.75 856.00(%)
  • SBI
    1,014.25 933.85(%)
  • ICICI Bank
    1,563.40 1,187.55(%)
  • Tata Steel
    192.05 224.40(%)
  • Sterlite Tech.
    683.20 84.65(%)
  • Multi Comm. Exc.
    3,603.80 3,552.00(%)
  • Larsen & Toubro
    4,095.25 3,288.65(%)
  • M & M
    3,264.00 2,743.15(%)
  • Data Pattern
    3,590.00 2,131.00(%)
  • Acutaas Chemical
    3,960.00 4,040.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Phaarmasia Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2597.0
  • ISIN : INE486I01016
82.00 0 (0.00%)
  • As on 08 Nov 2026 (EOD)

  • Today’s Low

    80.00

  • Today’s High

    82.00

  • Open

    80.00

  • Perv Close

    82.00

  • 52W Low

    30.60

  • 52W High

    131.75

Key Indicators

  • P/E(TTM)

    25.63

  • Mar.Cap (₹Cr.)

    56.01

  • Div & Yield %

    0.00

  • Book Value(₹)

    32.36

  • Debt-Equity Ratio

    0.00

  • AGM Date

    06-Nov-2026

  • EPS

    3.20

  • P/E Ratio

    25.63

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    56.01

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.83

  • BV (₹)

    32.40

  • Sales( ₹ in Cr.)

    47.21

  • NP (in Cr.)

    -4.80

  • NP Var(%)

    -202.0

  • Div%

    0.0

  • CPS (₹)

    -6.70

  • EPS (₹)

    -7.00

  • Traded Value (₹ in Lakhs)

    56.01

  • 52 Week High

    131.75

  • 52 Week Low

    30.60

  • Price BSE

    82.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    56.01

  • P/C Ratio

    -12.20

  • P/E Ratio

    -11.70

  • Price Vs.BV

    -7.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 47.21 24.37 30.59 27.49 17.22 16.26
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 47.21 24.37 30.59 27.49 17.22 16.26
Other Income 19.95 0.75 0.66 0.52 0.47 0.89
Stock Adjustments -0.28 -1.08 -0.60 1.67 0.49 -2.09
Total Income 66.88 24.04 30.65 29.68 18.18 15.06
EXPENDITURE :            
Raw Materials 33.22 18.38 24.01 24.13 14.35 12.49
Power and Fuel Cost 1.00 0.72 0.77 0.73 0.53 0.58
Employee Cost 2.61 1.68 1.53 1.41 1.17 1.36
Other Manufacturing Expenses 5.38 2.96 2.86 2.73 1.97 2.29
Selling and Administration Expenses 2.85 1.57 1.66 1.71 1.43 -2.49
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expenses 2.61 1.68 1.53 1.41 1.17 1.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 45.05 25.30 30.82 30.71 19.44 14.23
Operating Profit 21.82 -1.26 -0.16 -1.03 -1.27 0.83
Interest 0.22 0.02 0.04 0.04 0.00 0.01
Gross Profit 21.60 -1.28 -0.20 -1.07 -1.27 0.82
Depreciation 0.21 0.32 0.34 0.36 0.29 0.34
Profit Before Tax 21.39 -1.60 -0.54 -1.43 -1.56 0.48
Current Tax 3.71 0.00 0.00 0.00 0.00 0.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.10 -0.01 -0.03 -0.17 -0.02 -0.02
Reported Net Profit 17.57 -1.59 -0.52 -1.26 -1.55 0.31
Extraordinary Items 22.37 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -4.80 -1.59 -0.52 -1.26 -1.55 0.31
Adjustment below Net Profit 0.00 0.03 0.01 -0.01 0.31 0.00
P & L Balance brought forward -3.11 -1.51 -1.00 0.28 1.51 1.51
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 14.47 -3.07 -1.51 -1.00 0.28 1.82
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 25.74 -2.33 -0.76 -1.84 -2.27 0.46
Earnings Per Share(Adj)-Unit Curr 25.74 -2.33 -0.76 -1.84 -2.27 0.46
Book Value 32.37 6.58 8.87 9.62 11.45 13.79
Book Value(Adj)-Unit Curr 32.37 6.58 8.87 9.62 11.45 13.79

Shareholding Pattern

  • Promoter Group

    73.51%

  • Public Share Holding

    26.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,018,732 73.51 5,018,732 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,018,732 73.51 5,018,732 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 240 0.00 0 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,720 0.05 0 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,960 0.06 0 7
2] Non Institution
Bodies Corporate 9,697 0.14 5,246 60
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 16,335 0.24 16,335 14
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 26,305 0.39 26,305 34
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 539,354 7.90 539,354 6
Individuals holding nominal share capital up to Rs. 1 lakh 1,212,453 17.76 389,467 20,157
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,804,268 26.43 976,831 20,273
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,826,960 100.00 5,995,563 20,282

Company Background

Phaarmasia LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Phaarmasia Ltd
  • BSE Code : 2597.0
  • ISIN : INE486I01016

  • Incorporation Year

    1981

  • Registered Office

    16 Phase III
    I D A Jeedimetla, Hyderabad,
    Telangana-500055

  • Telephone

    91-40-23095002/23095690

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Urvashi Bhatia

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Phaarmasia Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Phaarmasia 82.00 48.17 47.21 3.17 18.60
Abbott India 26,684.90 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,480.05 2,304.07 2,275.58 91.15 27.86
Glaxosmi. Pharma 2,538.95 3,932.76 3,790.20 37.73 58.17
Evonile Pharma 1,814.05 393.10 354.33 -1,119.78 15.94
Cipla 1,410.95 20,102.60 18,979.95 43.00 13.88
Bliss GVS Pharma 620.10 773.53 729.81 40.42 12.51
Amrutanjan Healt 518.10 520.13 502.55 26.14 24.16
Fermenta Biotec. 454.65 474.15 450.25 21.49 18.77
Guj. Themis Bio. 385.75 168.25 165.82 103.14 18.05
Ambalal Sarabhai 35.51 19.52 3.94 60.19 6.77